Molecular Mechanism of Crataegi Folium and Alisma Rhizoma in the Treatment of Dyslipidemia Based on Network Pharmacology and Molecular Docking

Table 2

Top 10 key targets of dyslipidemia.

Targets	DC	BC	CC
CCND1	98	0.007020409	0.648514851
CASP3	76	0.017834894	0.708108108
HIF1A	75	0.011567789	0.685863874
ESR1	73	0.019366461	0.678756477
ERBB2	71	0.007947206	0.623809524
MYC	69	0.010977465	0.668367347
PTEN	69	0.013298088	0.655
TP53	66	0.023982438	0.735955056
AKT1	66	0.071732181	0.803680982
EGFR	65	0.022700048	0.693121693